For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit VaccineTogetherNY.org.
Weill Cornell Medicine scientists target some of the most formidable health challenges of the 21st century, including cancer, cardiovascular disease, metabolic diseases, neurodegenerative diseases such as Parkinson’s and Alzheimer’s, diseases affecting children, and infectious diseases, especially those with significant impact on the developing world.
Jonathan Shoag, M.D., Instructor in Urology (Urology), received a Damon Runyon Cancer Research Foundation grant to harness clinical data to identify new prostate cancer therapeutics.
